Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


1 Clin Infect Dis
1 Dig Dis Sci
3 Hepatology
1 J Clin Gastroenterol
3 J Hepatol
1 J Infect Dis
11 J Viral Hepat
1 PLoS One
2 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Clin Infect Dis

  1. FACENTE SN, Patel S, Hecht J, Wilson E, et al
    Hepatitis C care cascades for three populations at high risk: low-income trans women, young people who inject drugs, and men who have sex with men and inject drugs.
    Clin Infect Dis. 2021 Mar 26. pii: 6188771. doi: 10.1093.
    PubMed         Abstract available

    Dig Dis Sci

  2. LE E, Chee G, Kwan M, Cheung R, et al
    Treating the Hardest to Treat: Reframing the Hospital Admission as an Opportunity to Initiate Hepatitis C Treatment.
    Dig Dis Sci. 2021 Mar 26. pii: 10.1007/s10620-021-06941.
    PubMed         Abstract available


  3. JHAVERI R, Yee LM, Antala S, Murphy M, et al
    Responsible Inclusion of Pregnant Individuals in Eradicating Hepatitis C Virus.
    Hepatology. 2021 Mar 20. doi: 10.1002/hep.31825.
    PubMed         Abstract available

    Hip fracture risk in patients with cirrhosis: does diabetes mellitus matter?
    Hepatology. 2019 Feb 14. doi: 10.1002/hep.30560.
    PubMed         Abstract available

  5. LAI SW, Lin CL
    Hip fracture risk in patients with cirrhosis: does diabetes mellitus matter?
    Hepatology. 2019 Feb 14. doi: 10.1002/hep.30566.
    PubMed         Abstract available

    J Clin Gastroenterol

  6. LEE DU, Fan GH, Hastie DJ, Addonizio EA, et al
    The Impact of Malnutrition on the Hospital and Infectious Outcomes of Patients Admitted With Alcoholic Hepatitis: 2011 to 2017 Analysis of US Hospitals.
    J Clin Gastroenterol. 2021 Mar 25. pii: 00004836-900000000-97444.
    PubMed         Abstract available

    J Hepatol

  7. CALVARUSO V, Bruix J
    Towards personalized screening for hepatocellular carcinoma: still not there.
    J Hepatol. 2020 Aug 5. pii: S0168-8278(20)30405.

  8. CRESPO J, Lazarus JV, Iruzubieta P, Garcia F, et al
    Let's leverage SARS-CoV2 vaccination to screen for hepatitis C screening in Spain, in Europe, around the world.
    J Hepatol. 2021 Mar 20. pii: S0168-8278(21)00181.

  9. INOUE T, Kusumoto S, Iio E, Ogawa S, et al
    Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivation.
    J Hepatol. 2021 Feb 26. pii: S0168-8278(21)00151.
    PubMed         Abstract available

    J Infect Dis

  10. KAPPUS MR, Wolfe CR, Muir AJ
    Direct-Acting Antivirals and Organ Transplantation: Is There Anything We Can't Do?
    J Infect Dis. 2020;222.
    PubMed         Abstract available

    J Viral Hepat

  11. PLATT L, French CE, McGowan CR, Sabin K, et al
    Prevalence and burden of HBV co-infection among people living with HIV: A global systematic review and meta-analysis.
    J Viral Hepat. 2020;27:294-315.
    PubMed         Abstract available

  12. DARVISHIAN M, Wong S, Binka M, Yu A, et al
    Loss to follow-up: A significant barrier in the treatment cascade with direct-acting therapies.
    J Viral Hepat. 2020;27:243-260.
    PubMed         Abstract available

  13. FARAG MS, Fung S, Tam E, Doucette K, et al
    Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real-World Study.
    J Viral Hepat. 2021 Mar 22. doi: 10.1111/jvh.13500.
    PubMed         Abstract available

  14. POST G, Howell J, Sow A, Ndow G, et al
    Clinical utility of quantifying hepatitis B surface antigen in African patients with chronic hepatitis B.
    J Viral Hepat. 2021 Mar 22. doi: 10.1111/jvh.13499.
    PubMed         Abstract available

  15. MACGREGOR L, Ward Z, Martin NK, Nicholls J, et al
    The cost-effectiveness of case-finding strategies for achieving hepatitis C elimination among men who have sex with men in the UK.
    J Viral Hepat. 2021 Mar 24. doi: 10.1111/jvh.13503.
    PubMed         Abstract available

  16. BAIANO CX, Caven M, Robinson EM, Dillon JF, et al
    Evaluating and communicating hepatitis C cascades of care data in Tayside, Scotland: A journey towards elimination.
    J Viral Hepat. 2021 Mar 24. doi: 10.1111/jvh.13505.
    PubMed         Abstract available

  17. LIU CH, Sun HY, Hsieh SM, Liu WC, et al
    Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct acting antivirals and antiretroviral therapy.
    J Viral Hepat. 2021 Mar 24. doi: 10.1111/jvh.13502.
    PubMed         Abstract available

  18. JI JH, Park SY, Son WJ, Shin HJ, et al
    External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals.
    J Viral Hepat. 2021 Mar 24. doi: 10.1111/jvh.13506.
    PubMed         Abstract available

  19. SAMALA N, Abdallah W, Poole A, Shamseddeen H, et al
    Insight Into The Acute hepatitis A Outbreak In Indiana.
    J Viral Hepat. 2021 Mar 24. doi: 10.1111/jvh.13504.
    PubMed         Abstract available

  20. BUTT AA, Yan P
    Natural History of Hepatitis C Virus Infection in a Large National Seroconversion Cohort in the Direct Acting Antiviral Agent Era: Results from ERCHIVES.
    J Viral Hepat. 2021 Mar 24. doi: 10.1111/jvh.13507.
    PubMed         Abstract available

  21. RODRIGUEZ-TAJES S, Pocurull A, Lens S, Marino Z, et al
    Efficacy of an accelerated double dose Hepatitis B vaccine regimen in patients with cirrhosis.
    J Viral Hepat. 2021 Mar 24. doi: 10.1111/jvh.13509.
    PubMed         Abstract available

    PLoS One

  22. ATALAY AA, Abebe RK, Dadhi AE, Bededa WK, et al
    Seroprevalence of hepatitis B virus among pregnant women attending Antenatal care in Dilla University Referral Hospital Gedio Zone, Ethiopia; health facility based cross-sectional study.
    PLoS One. 2021;16:e0249216.
    PubMed         Abstract available


  23. DEERIN JF, Clifton R, Elmi A, Lewis PE, et al
    Hepatitis B birth dose vaccination patterns in the military health System, 2014-2018.
    Vaccine. 2021 Mar 16. pii: S0264-410X(21)00278.
    PubMed         Abstract available

  24. SUSARLA SK, Palkar S, Sv PS, Diwan A, et al
    Safety and immunogenicity of inactivated hepatitis-A vaccine developed by Human Biologicals Institute in two age groups of healthy subjects: A phase I open label study.
    Vaccine. 2021 Mar 16. pii: S0264-410X(21)00280.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.